Strongbridge Biopharma plc
SBBPDelisted Oct 5, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634432
Strongbridge Biopharma plc was delisted on Oct 5, 2021; its insiders filed their last Form 4 on Jan 5, 2022; 49 institutions reported holding it in 13F filings for Q3 2021, worth $69.8M in total; Fairfax Financial was the only superinvestor holding it.
Holders of 5% or more of SBBP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Strongbridge Biopharma plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Strongbridge Biopharma plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Strongbridge Biopharma plc, newest first.
No Schedule 13D or 13G filings on Strongbridge Biopharma plc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Strongbridge Biopharma plc shares.
No Form 144 notices for Strongbridge Biopharma plc are on file.